Department of Paediatrics, School for Oncology and Developmental Biology (GROW), Maastricht University Medical Centre, Maastricht, The Netherlands.
J Pediatr. 2010 Jan;156(1):10-15.e1. doi: 10.1016/j.jpeds.2009.07.044.
To study the association between antenatal exposure to chorioamnionitis and the neonatal response to surfactant.
Prospective observational cohort of 301 preterm infants of gestational age < or = 32.0 weeks, 146 of whom received surfactant according to standardized criteria. Fraction of inspired oxygen (FiO(2)) requirement (using analysis of variance) and time to extubation (using Kaplan-Meier and Cox regression analyses) were compared between groups based on the presence of histological chorioamnionitis (HC) with or without fetal involvement (HC-, n = 88; HC + F-, n = 25; HC + F+, n = 33) and between infants who developed bronchopulmonary dysplasia (BPD) or died (n = 57) and BPD-free survivors (n = 89). Multiple logistic regression was performed to investigate the association between HC and BPD.
Compared with HC- infants, HC + F+ infants had significantly greater FiO(2) requirement and prolonged time to extubation postsurfactant, not accounted for by differences in gestational age and birth weight. Infants with BPD/death had a strikingly similar pattern of increased FiO(2) requirement postsurfactant. Moreover, in infants who received surfactant, HC + F+ status was associated with increased risk for BPD (odds ratio [OR] = 3.40; 95% confidence interval [CI] = 1.02-11.3; P = .047) and for BPD/death (OR = 2.72; 95% CI = 1.00-7.42; P = .049).
An impaired surfactant response was observed in preterm infants with severe chorioamnionitis and may be involved in the association between chorioamnionitis, mechanical ventilation, and the development of BPD.
研究产前绒毛膜羊膜炎与新生儿表面活性物质反应之间的关系。
对 301 例胎龄<或=32.0 周的早产儿进行前瞻性观察队列研究,其中 146 例根据标准化标准接受表面活性物质治疗。根据有无胎儿受累(HC-,n=88;HC+F-,n=25;HC+F+,n=33)和是否发生支气管肺发育不良(BPD)或死亡(n=57)与 BPD 存活者(n=89)比较,采用方差分析比较两组吸入氧分数(FiO2)需求(采用方差分析)和拔管时间(采用 Kaplan-Meier 和 Cox 回归分析)。采用多因素逻辑回归分析探讨 HC 与 BPD 的关系。
与 HC-婴儿相比,HC+F+婴儿在接受表面活性物质治疗后,FiO2 需求显著增加,拔管时间延长,而这与胎龄和出生体重的差异无关。BPD/死亡婴儿的 FiO2 需求增加模式非常相似。此外,在接受表面活性物质治疗的婴儿中,HC+F+状态与 BPD 的风险增加相关(比值比[OR] = 3.40;95%置信区间[CI] = 1.02-11.3;P=0.047)和 BPD/死亡(OR=2.72;95%CI=1.00-7.42;P=0.049)。
严重绒毛膜羊膜炎的早产儿表面活性物质反应受损,可能与绒毛膜羊膜炎、机械通气和 BPD 的发生有关。